Pharmagest Interactive: EQUASENS (Pharmagest Interactive): Q1 2022 revenue: +9.03% to 49.36m

Villers-lès-Nancy, 12 May 2022 - 6:00 p.m. (CET) PRESS RELEASE Q1 2022 revenue: +9.03% to €49.36m Name change completed: Pharmagest Group becomes Equasens Group The Extraordinary General Meeting of 6 May 2022 adopted the resolution changing Pharmagest Group's name to Equasens Group. Group's Q1 2022 revenue up 9.03% to €49.36m (+7% to €48.44m like-for-like). The Group [...]